Fibrinogen and factor VII levels improve with glycemic control in patients with type 1 diabetes mellitus who have microvascular complications

Archives of Internal Medicine

Volumn 161, Issue 1, 2001, Pages 98-101

  D'Elia, John A ^a,f,g   Weinrauch, Larry A ^a,b,f   Gleason, Ray E ^d,f   Lipinska, Izabela ^c,f   Keough, Joanne ^a   Pendse, Shona ^f   Roshan, Bijan ^a,f   Lee, Annette T ^e   Tofler, Geoffrey H ^c,f  

^a JOSLIN DIABETES CENTER   (United States)

^b MOUNT AUBURN HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e PICOWER INST FOR MEDICAL RESEARCH   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; FIBRINOGEN; INSULIN;

ADULT; ARTICLE; BLOOD CLOTTING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; GLUCOSE BLOOD LEVEL; GLYCOSYLATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MICROVASCULARIZATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; THROMBOEMBOLISM; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0035825271     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.1.98     Document Type: Article

References (27)

1. Angiographic assessment in diabetics evaluated for renal transplantation
2. Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: Incidence and risk factors
3. Proteinuria: Value as a predictor of cardiovascular mortality in insulin dependent diabetes mellitus
4. Effect of proteinuria on mortality in NIDDM
5. Hyperfibrinogenemia: An important risk factor for vascular complications in diabetes
6. Fibrinolytic activity, clotting factors and the long-term incidence of ischemic heart disease in the Northwick Park heart study
7. Weekly pulsatile IV insulin treatments appear to slow progression of diabetic nephropathy
8. Gerinnungsphysiologisiche schnellmethode zur bestimmung des fibrinogens
9. A standardized fibrin plate method and fibrinolytic assay of plasminogen
10. Immunochemical detection of advanced glycosylation end-products in vivo
11. Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans
12. Differential effects on insulin deficiency on albumin and fibrinogen synthesis in humans
13. Reduced fibrinogen survival in diabetes mellitus
14. Postprandial elevation of activated factor VII in young adults
15. Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men
16. Haemostatic abnormalities persist despite glycemic improvement by insulin therapy in lean type 2 diabetic patients
17. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus
18. Factor VII coagulant activity (VIIc) and hypercoagulability in chronic renal disease and dialysis: Relationship with dyslipidaemia, inflammation, and factor VII genotype
19. Prothrombotic and antithrombotic factors are elevated in patients with type 1 diabetes complicated by microalbuminuria
20. Enhancement of spontaneous fibrinolytic activity in diabetic retinopathy
21. Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors
22. Changes in serum amylase, lipase and leukocyte elastase during diabetic ketoacidosis and poorly controlled diabetes
23. Proteolytic enzymes and catabolism: Enhanced release of granulocyte proteinases in uremic intoxication and during hemodialysis
24. Miniplasminogen-like fragments of plasminogen in synovial fluid in acute inflammatory arthritis
25. Effects of pulsatile intravenous insulin therapy (PIVIT) on the progression of diabetic nephropathy
26. Fibrinogen is a strong predictor of mortality in diabetics: 8 Year prospective follow-up
27. Diabetes mellitus: A major risk factor for cardiovascular disease